Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
05/13/2010
Trade Name:
Taxotere
Generic or Proper Name (*):
docetaxel
Indications Studied:
Solid Tumors
Therapeutic Category:
Antineoplastic
Ages Studied:
1 - 26 years
Study #:
2
Study Type:
Efficacy/Safety
Study Design:
Open Label
No Patients:
178
No Centers:
46
No Countries:
3
BPCA(B), PREA(P):
B
Asian:
5
Black:
24
Other:
3
White:
110
Native Hawaiian or Pacific Islander:
4
American Indian/Alaska Native:
0
Hispanic/Latino:
32
Non-Hispanic/Non Latino:
0
-
-